Doctors Note Logo

Published on: 9/29/2026

What Frontotemporal Dementia Is, and Why It Starts With Personality

Frontotemporal dementia (FTD) is a group of brain disorders caused by progressive nerve cell loss in the frontal and temporal lobes, the regions that govern personality, behavior, judgment, and language. Because these areas control social conduct rather than memory, the earliest signs are often drastic personality shifts such as apathy, loss of empathy, socially inappropriate remarks, impulsive spending, compulsive rituals, or new food cravings, which is why FTD is frequently mistaken for depression, bipolar disorder, or a midlife crisis. It typically begins between ages 45 and 65, far earlier than Alzheimer's disease, and memory often stays relatively intact in the early stages. Several important distinctions separate FTD from other dementias and mental health conditions, including subtype differences, genetic risk, and red flags that warrant urgent evaluation, so see below to understand more.

If personality, behavior, or language changes are worrying you or someone you love, the details matter, and guessing can delay care that could make a real difference. Take a free, instant, online symptom check to organize what you are noticing, understand which conditions may explain it, and get clear guidance on the right next step and the type of specialist to see.

Last reviewed for medical accuracy: 09/29/2026

answer background

Explanation

What Is Frontotemporal Dementia, and Why It Starts With Personality

Frontotemporal dementia (FTD) is a group of brain disorders that primarily affect the frontal and temporal lobes. These areas control personality, behavior, language and some aspects of movement. Unlike Alzheimer’s disease, which often begins with memory loss, FTD typically starts with changes in personality or language skills. Understanding what frontotemporal dementia is can help you recognize early signs and seek appropriate care.

Key Facts About Frontotemporal Dementia

  • Frontotemporal dementia is the third most common cause of dementia in people under 65.
  • Onset usually occurs between ages 45 and 65, though it can appear earlier or later.
  • There is no cure, but early diagnosis and support can improve quality of life.
  • FTD may run in families in about 20–40% of cases.

Why Personality Changes Are Often First

The frontal lobes are the brain’s “control center” for behavior, decision-making and social conduct. The temporal lobes handle language comprehension and emotional tone. When these regions begin to deteriorate:

  • Behavioral Control Declines
    • Disinhibition (acting without regard for social rules)
    • Impulsivity (sudden urges or risky decisions)
    • Loss of empathy or tact

  • Motivation and Initiative Wane
    • Apathy or indifference to work, hobbies and relationships
    • Social withdrawal or neglect of personal care

  • Emotional Regulation Shifts
    • Flat or inappropriate emotional responses
    • Unusual outbursts of laughter or tears

Because these changes can look like a mood or personality disorder, FTD is often misdiagnosed at first. Over time, more classic cognitive and language problems emerge.

Main Types of Frontotemporal Dementia

  1. Behavioral Variant FTD (bvFTD)

    • Most common form (about 60% of FTD cases)
    • Early personality and behavior changes
    • Compulsive behaviors (repeated movements, hoarding)
    • Changes in eating habits (craving sweets or overeating)
  2. Primary Progressive Aphasia (PPA)

    • Affects language areas in the left temporal lobe
    • Two subtypes:
      • Nonfluent/agrammatic variant: effortful speech, grammar problems
      • Semantic variant: loss of word meaning, difficulty naming objects
  3. FTD with Motor Symptoms

    • Overlaps with movement disorders like amyotrophic lateral sclerosis (ALS) or corticobasal syndrome
    • Stiffness, muscle weakness or tremors may develop

How FTD Differs From Other Dementias

  • Memory is often preserved in early stages, unlike Alzheimer’s.
  • Language or behavior is the first to go, rather than short-term memory.
  • Progression can be faster, with significant decline within 5–8 years.
  • Brain scans typically show shrinkage (atrophy) in frontal or temporal lobes.

What Causes Frontotemporal Dementia?

FTD is linked to abnormal protein deposits in brain cells:

  • Tau Protein: Forms tangled clumps that disrupt cell function.
  • TDP-43 Protein: Accumulates in nerve cell nuclei and cytoplasm.
  • FUS Protein: Less common, but also causes toxic buildups.

Genetics play a role in many cases. Mutations in genes such as MAPT, GRN and C9orf72 can be inherited. A family history of FTD, ALS or related disorders increases risk.

Recognizing Early Symptoms

Because personality changes are often subtle, they can slip under the radar. Common early signs include:

  • Loss of interest in favorite activities
  • Unexplained irritability or euphoria
  • Inappropriate jokes or remarks
  • Reduced empathy for friends or family
  • New repetitive actions (tapping, pacing)
  • Word-finding difficulties or odd speech patterns

If you or a loved one notice these changes, it’s important to seek evaluation sooner rather than later. You might even try a free, online symptom check, using the doctor approved Ubie Symptom Checker to help track and clarify early concerns.

Diagnosing Frontotemporal Dementia

  1. Clinical Evaluation

    • Detailed medical and family history
    • Neurological exam focusing on behavior and language
  2. Cognitive and Behavioral Testing

    • Assessments of speech, memory, judgment and executive function
  3. Brain Imaging

    • MRI or CT scans to detect atrophy in frontal/temporal lobes
    • PET scans to reveal metabolic changes
  4. Genetic Testing

    • Offered if there’s a family history of FTD or related conditions

Differential diagnosis rules out other causes of personality change, such as depression, bipolar disorder, drug side effects or other neurological diseases.

Managing Frontotemporal Dementia

While there’s no cure, a combination of strategies can improve daily life:

  • Behavioral Interventions
    • Structured routines and clear expectations
    • Redirecting repetitive behaviors
    • Gentle reminders for personal care

  • Speech and Language Therapy
    • Techniques to maintain communication skills
    • Alternative communication methods (picture boards, apps)

  • Medications (Off-Label Use)
    • Selective serotonin reuptake inhibitors (SSRIs) for compulsive behavior
    • Antipsychotics in low doses for severe disinhibition (used cautiously)

  • Support for Caregivers
    • Education about FTD and coping strategies
    • Respite care and support groups

Tips for Families and Caregivers

  • Keep tasks and expectations simple and predictable.
  • Use calendars, labels and reminders to assist with daily routines.
  • Focus on remaining strengths—engage in music, art or gentle exercise.
  • Establish a calm environment to reduce agitation.
  • Seek professional help for legal and financial planning early.

Looking Ahead

Research into FTD aims to clarify the exact mechanisms of protein buildup and to develop targeted therapies. Clinical trials are ongoing for medications that may slow progression.

Early recognition of personality changes and language difficulties remains crucial. If you suspect something is off, taking action now can lead to better planning and care.

Remember: this information is not a substitute for professional medical advice. Always speak to a doctor about any symptoms that could be serious or life-threatening.

(References)

  • * Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I. Apathy is not depression. J Neuropsychiatry Clin Neurosci. 1998 Summer;10(3):314-9. doi: 10.1176/jnp.10.3.314. PMID: 9706539.

  • * Miller ZA, Miller BL. Artistic creativity and dementia. Prog Brain Res. 2013;204:99-112. doi: 10.1016/B978-0-444-63287-6.00005-1. PMID: 24041320.

  • * Franken G. [Insidiously into the crisis]. Krankenpfl Soins Infirm. 2013;106(9):8-11, 56-9, 78-81. PMID: 24046952.

  • * Miller BL, Dickerson BC, Lucente DE, Larvie M, Frosch MP. Case records of the Massachusetts General Hospital. Case 9-2015. A 31-year-old man with personality changes and progressive neurologic decline. N Engl J Med. 2015 Mar 19;372(12):1151-62. doi: 10.1056/NEJMcpc1409839. PMID: 25785973; PMCID: PMC4795456.

  • * Miller BL, Dickerson BC. Case 9-2015: A Man with Personality Changes and Progressive Neurologic Decline. N Engl J Med. 2015 Jul 30;373(5):486. doi: 10.1056/NEJMc1505794. PMID: 26222576; PMCID: PMC5774981.

  • * Lawn B. Case 9-2015: A Man with Personality Changes and Progressive Neurologic Decline. N Engl J Med. 2015 Jul 30;373(5):486. doi: 10.1056/NEJMc1505794. PMID: 26222577.

  • * Bonner MF, Price AR, Peelle JE, Grossman M. Semantics of the Visual Environment Encoded in Parahippocampal Cortex. J Cogn Neurosci. 2016 Mar;28(3):361-78. doi: 10.1162/jocn_a_00908. Epub 2015 Dec 17. PMID: 26679216; PMCID: PMC4861322.

  • * Mula M, Hermann B, Trimble MR. Neuropsychiatry of creativity. Epilepsy Behav. 2016 Apr;57(Pt B):225-9. doi: 10.1016/j.yebeh.2015.12.050. Epub 2016 Feb 11. PMID: 26876274.

  • * Reber J, Tranel D. Frontal lobe syndromes. Handb Clin Neurol. 2019;163:147-164. doi: 10.1016/B978-0-12-804281-6.00008-2. PMID: 31590727.

  • * Magno MA, Canu E, Agosta F, Filippi M. Measuring social cognition in frontotemporal lobar degeneration: a clinical approach. J Neurol. 2022 Apr;269(4):2227-2244. doi: 10.1007/s00415-021-10889-9. Epub 2021 Nov 19. PMID: 34797433.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.